Home LiteratureArticle Details
PMID: 15499040 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Uterine spiral artery remodeling involves endothelial apoptosis induced by extravillous trophoblasts through Fas/FasL interactions.

Arteriosclerosis, thrombosis, and vascular biology ·Vol. 25 ·No. 1 ·2005-01-00 ·Pages 102-8

Ashton SV, Whitley GS, Dash PR, Wareing M, Crocker IP, Baker PN, Cartwright JE

Abstract

Invasion of uterine spiral arteries by extravillous trophoblasts in the first trimester of pregnancy results in loss of endothelial and musculoelastic layers. This remodeling is crucial for an adequate blood supply to the fetus with a failure to remodel implicated in the etiology of the hypertensive disorder preeclampsia. The mechanism by which trophoblasts induce this key process is unknown. This study gives the first insights into the potential mechanisms involved. Spiral arteries were dissected from nonplacental bed biopsies obtained at Caesarean section, and a novel model was used to mimic in vivo events. Arteries were cultured with trophoblasts in the lumen, and apoptotic changes in the endothelial layer were detected after 20 hours, leading to loss of endothelium by 96 hours. In vitro, coculture experiments showed that trophoblasts stimulated apoptosis of primary decidual endothelial cells and an endothelial cell line. This was blocked by caspase inhibition and NOK2, a FasL blocking antibody. NOK2 also abrogated trophoblast-induced endothelial apoptosis in the vessel model. Extravillous trophoblast induction of endothelial apoptosis is a possible mechanism by which the endothelium is removed, and vascular remodeling may occur in uterine spiral arteries. Fas/FasL interactions have an important role in trophoblast-induced endothelial apoptosis.

MeSH Terms
Apoptosis/physiology Arteries/metabolism,pathology Cells, Cultured Endothelial Cells/pathology Endothelium, Vascular/pathology Fas Ligand Protein Female Humans Membrane Glycoproteins/metabolism Trophoblasts/metabolism Uterus/blood supply fas Receptor/metabolism
Chemicals
FASLG protein, human Fas Ligand Protein Membrane Glycoproteins fas Receptor
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Ashton Sandra V
Biochemistry and Immunology Department of Basic Medical Sciences, St. George's Hospital Medical School, Cranmer Terrace, London, UK.
Whitley Guy St J
Dash Philip R
Wareing Mark
Crocker Ian P
Baker Philip N
Cartwright Judith E
References (30)
30 references, click to expand
  1. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP).
    Circ Res. 2001 Jul 6;89(1):13-9 PMID: 11440972
  2. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy.
    Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):309-16 PMID: 10669625
  3. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus.
    J Immunol. 1997 May 1;158(9):4122-8 PMID: 9126971
  4. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8.
    J Immunol. 2000 Jun 15;164(12):6100-4 PMID: 10843658
  5. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature.
    Am J Obstet Gynecol. 2002 Nov;187(5):1416-23 PMID: 12439541
  6. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy.
    Placenta. 1980 Jan-Mar;1(1):3-19 PMID: 7443635
  7. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
    Exp Cell Res. 2000 Apr 10;256(1):58-66 PMID: 10739652
  8. The long-term outcome of retarded fetal growth.
    Clin Obstet Gynecol. 1997 Dec;40(4):853-63 PMID: 9429799
  9. Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts.
    Placenta. 1998 May;19(4):241-52 PMID: 9639319
  10. Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide.
    Br J Pharmacol. 1999 Sep;128(1):181-9 PMID: 10498850
  11. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance.
    Nat Immunol. 2001 Nov;2(11):1018-24 PMID: 11590404
  12. Trophoblast invasion of spiral arteries: a novel in vitro model.
    Placenta. 2002 Feb-Mar;23(2-3):232-5 PMID: 11945091
  13. The phagocytic activity of human first trimester extravillous trophoblast.
    Hum Reprod. 1998 Oct;13(1O):2941-9 PMID: 9804259
  14. Endothelial cell apoptosis in angiogenesis and vessel regression.
    Circ Res. 2000 Sep 15;87(6):434-9 PMID: 10988233
  15. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?
    J Clin Invest. 1997 May 1;99(9):2139-51 PMID: 9151786
  16. Vascular cell apoptosis in remodeling, restenosis, and plaque rupture.
    Circ Res. 2000 Aug 4;87(3):184-8 PMID: 10926867
  17. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus.
    J Clin Endocrinol Metab. 1999 Jun;84(6):2188-94 PMID: 10372730
  18. A novel in vitro model of trophoblast-mediated decidual blood vessel remodeling.
    Lab Invest. 2003 Dec;83(12 ):1821-8 PMID: 14691300
  19. A possible role for activated complement component 3 in phagocytic activity exhibited by the mouse trophoblast.
    Am J Reprod Immunol. 1999 May;41(5):343-52 PMID: 10378030
  20. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis.
    Mol Hum Reprod. 2004 Jan;10(1):55-63 PMID: 14665707
  21. Metalloproteinase-mediated release of human Fas ligand.
    J Exp Med. 1995 Dec 1;182(6):1777-83 PMID: 7500022
  22. Modification of endometrial arteries during invasion by cytotrophoblast cells in the pregnant macaque.
    Acta Anat (Basel). 1997;159(4):169-93 PMID: 9605602
  23. The expression and release of adhesion molecules by human endothelial cell lines and their consequent binding of lymphocytes.
    Exp Cell Res. 1995 Apr;217(2):329-35 PMID: 7698233
  24. Update on pathways regulating the activation of uterine Natural Killer cells, their interactions with decidual spiral arteries and homing of their precursors to the uterus.
    J Reprod Immunol. 2003 Aug;59(2):175-91 PMID: 12896821
  25. FAS/FAS ligand interaction at the placental interface is not required for the success of allogeneic pregnancy in anti-paternal MHC preimmunized mice.
    Am J Reprod Immunol. 2001 Feb;45(2):108-15 PMID: 11216873
  26. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia.
    Circ Res. 2002 Jun 28;90(12):1274-81 PMID: 12089065
  27. Cell culture models of human trophoblast II: trophoblast cell lines--a workshop report.
    Placenta. 2001 Apr;22 Suppl A:S104-6 PMID: 11312640
  28. Nitric oxide inhibits polyamine-induced apoptosis in the human extravillous trophoblast cell line SGHPL-4.
    Hum Reprod. 2003 May;18(5):959-68 PMID: 12721169
  29. Nitric oxide protects human extravillous trophoblast cells from apoptosis by a cyclic GMP-dependent mechanism and independently of caspase 3 nitrosylation.
    Exp Cell Res. 2003 Jul 15;287(2):314-24 PMID: 12837287
  30. The isolation, characterization and culture of human decidual endothelium.
    Hum Reprod. 1995 Aug;10(8):2142-8 PMID: 8567856
Article Info
Journal
Arteriosclerosis, thrombosis, and vascular biology
Abbr.
Arterioscler Thromb Vasc Biol
ISSN
1524-4636
Published
2005-01-00
Epub
2004-00-21
Pages
102-8
Language
English
Region
United States
NLM ID
9505803
PMCID
PMC4228192
Subset
IM
Grants
British Heart Foundation · PG/2001045/12838 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com